Shanghai Pharmaceuticals Holding
Pre-Approval PRO BETASlowing Activity
No new clinical trials started in 1-2 years. Monitor for changes in pipeline strategy. Last trial started: 3/2/2025
Pipeline by Phase
Therapeutic Focus
Clinical Trials (30)
Study to Evaluate the Efficacy and Safety of SPH3127 In Patients With Mild-moderate Essential Hypertension
Started: 6/10/2021
Safety and Efficacy of SPH4336 in Combination With Endocrine Therapy in the Treatment of Locally Advanced or Metastatic Breast Cancer
Started: 9/8/2023
A Clinical Study of SPH5030 Tablets in the Treatment of Her2-positive/Mutated Biliary Tract OR Colorectal Cancer Patients.
Started: 7/17/2024
Phase II/III Study of SPH4336 Combined With Letrozole vs Placebo Combined With Letrozole in First-line Treatment of Breast Cancer
Started: 4/24/2023
Efficacy and Safety of SPH4336 in Combination With Endocrine Therapy in Breast Cancer Patients With Brain Metastases.
Started: 9/19/2023
Efficacy and Safety of LT3001 on Treating the Acute Ischemic Stroke
Started: 4/6/2023
A Clinical Study of TK216 in Patients With Relapsed or Refractory Ewing's Sarcoma
Started: 3/12/2024
A Study of SPH3127 in the Treatment of Mild to Moderate Ulcerative Colitis
Started: 6/19/2023
Efficacy and Safety of SPH3127 Tablets on Treating the Diabetic Kidney Disease
Started: 3/22/2023
Safety and Efficacy of T8 on Treating Chronic Abnormal Immune Activation in HIV/AIDS Patients
Started: 12/25/2019
Safety and Efficacy of SPH3127 on Treating Mild-moderate Essential Hypertension Patients
Started: 1/11/2019
Phase II Clinical Study of Thalidomide in the Treatment of Ankylosing Spondylitis
Started: 2/1/2013
A Clinical Study of T3011 in Subjects With Advanced Melanoma
Started: 1/26/2024
A Study to Efficacy and Safety of SPH4336 Monotherapy or in Combination With Cadonilimab in Patients With Advanced Solid Tumors.
Started: 10/17/2023
A Clinical Study of SPH7485 Tablets in the Treatment of Advanced Solid Tumors.
Started: 8/6/2024
A Clinical Study of SPH9788 Tablets in Healthy Chinese Subjects.
Started: 3/2/2025
A Clinical Study of T3011 in Combination With PD-1/PD-L1 Inhibitors in Subjects With Advanced Solid Tumors
Started: 1/11/2024
Clinical Study of SPH3348 Tablets, a C-Met Inhibitor, in Patients with Advanced Solid Tumors
Started: 7/2/2020
Phase I Clinical Study of SPH4336 Tablets in the Treatment of Advanced Solid Tumors
Started: 11/3/2020
B003 in Patients With HER2-positive Recurrent or Metastatic Breast Cancer
Started: 4/1/2019
Single Ascending Dose Study of Safety and Tolerability of SPH3127 Tablet in Chinese Healthy Volunteers
Started: 12/1/2016
B001 in Patients With CD20 Positive B-cell Non Hodgkin's Lymphoma
Started: 3/22/2018
The Tolerability and Pharmacokinetics of Multiple Doses of SPH3127 in Chinese Healthy People
Started: 10/23/2017
The Effect of Food Intake on the Pharmacokinetic of Single Dose SPH3127 Tablets in Chinese Health Subjects
Started: 9/23/2017
Hydroxytriptolide in Active Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate
Started: 6/1/2014